Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CSTK advanced for three days, in 48 of 55 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on CSTK as a result. In 17 of 20 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for CSTK just turned positive on October 07, 2026. Looking at past instances where CSTK's MACD turned positive, the stock continued to rise in 9 of 13 cases over the following month. The odds of a continued upward trend are 69%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for CSTK crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 1 of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 33%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
CSTK broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CSTK entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where FITB declined for three days, in 174 of 264 cases, the price declined further within the following month. The odds of a continued downward trend are 66%.
The Momentum Indicator moved below the 0 level on September 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FITB as a result. In 50 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.
The Aroon Indicator for FITB entered a downward trend on September 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FITB's RSI Oscillator exited the oversold zone, 21 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 35 of 50 cases where FITB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for FITB just turned positive on October 08, 2026. Looking at past instances where FITB's MACD turned positive, the stock continued to rise in 34 of 48 cases over the following month. The odds of a continued upward trend are 71%.
FITB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 6 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. FITB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 57 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock slightly worse than average.
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.448) is normal, around the industry mean (1.323). P/E Ratio (17.364) is within average values for comparable stocks, (23.509). Projected Growth (PEG Ratio) (1.638) is also within normal values, averaging (1.190). Dividend Yield (0.031) settles around the average of (0.030) among similar stocks. P/S Ratio (3.854) is also within normal values, averaging (3.738).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
FITB | ||
|---|---|---|
OUTLOOK RATING 1..100 | 75 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 60 Fair valued | |
PROFIT vs RISK RATING 1..100 | 57 | |
SMR RATING 1..100 | 6 | |
PRICE GROWTH RATING 1..100 | 57 | |
P/E GROWTH RATING 1..100 | 21 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CSTK | FITB | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 78% |
| Stochastic ODDS (%) | 2 days ago 40% | 2 days ago 70% |
| Momentum ODDS (%) | 2 days ago 85% | 2 days ago 57% |
| MACD ODDS (%) | 2 days ago 69% | 2 days ago 71% |
| TrendWeek ODDS (%) | 2 days ago 76% | 2 days ago 63% |
| TrendMonth ODDS (%) | 2 days ago 31% | 2 days ago 60% |
| Advances ODDS (%) | 4 days ago 87% | N/A |
| Declines ODDS (%) | 2 days ago 55% | 2 days ago 66% |
| BollingerBands ODDS (%) | 2 days ago 53% | 2 days ago 65% |
| Aroon ODDS (%) | 2 days ago 36% | 2 days ago 57% |
A.I.dvisor indicates that over the last year, CSTK has been loosely correlated with EMR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTK jumps, then EMR could also see price increases.
| Ticker / NAME | Correlation To CSTK | 1D Price Change % | ||
|---|---|---|---|---|
| CSTK | 100% | -0.45% | ||
| EMR - CSTK | 59% Loosely correlated | -1.48% | ||
| HBAN - CSTK | 52% Loosely correlated | -0.92% | ||
| FITB - CSTK | 52% Loosely correlated | -1.15% | ||
| CFG - CSTK | 49% Loosely correlated | -1.15% | ||
| CAT - CSTK | 49% Loosely correlated | -3.08% | ||
More | ||||